Philadelphia, PA · Founded 2022 · Privately Held (backing)
Developer of a cell-based therapeutic platform intended to overcome bottlenecks in gene therapy manufacturing. BlueWhale Bio is based in Philadelphia, PA and was founded in 2022. It was valued at $52 million at its early-stage round in Oct 2025, the last priced event on record. It has raised $23 million across 1 recorded round; the latest was a $5 million early-stage round in Oct 2025.
These 5 firms already write checks for companies like BlueWhale Bio. Build the wider list: every firm that has backed a company like this one, ranked by how often and how recently.